European Pharma Days

Join us for the European Pharma Days taking place on April 27 - 28 in Mannheim, Germany, organized by Bruker, M2Aind and CeMOS – Center for Mass Spectrometry and Optical Spectroscopy.

Join several industry leaders from top pharma around the globe as they present their perspectives on advanced MS based technologies like trapped ion mobility and MALDI Imaging and how these new technologies are transforming drug discovery. This two day event will cover applications within biologics characterization (day 1) and MALDI Imaging (day 2) with speakers from Novozymes, Janssen, Octapharma, Boehringer Ingelheim, Sanofi, Ambergen and PreOmics. 

From lead generation to pre-clinical assessment, Bruker has built on years of excellence in mass spectrometry to impact the pharmaceutical industry. It is a great opportunity to learn from key users in the industry how to maximize these new workflows.

Aula, Building C

Mannheim University of Applied Sciences

Hochschule Mannheim

Paul-Wittsack-Straße 10

68163 Mannheim

10:00 - 11:00 Registration

11:00 - 11:10 Opening
Prof. Dr. Mathias Hafner, VP Research and Transfer, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
Dr. Eric van Beelen, Bruker Netherland B.V., Leiderdorp, Netherlands

Chair: Prof. Dr. Carsten Hopf, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

11:10 - 12:00 Keynote Speaker: Prof. Dr. Matthias Mann, Max-Planck-Institute for Biochemistry, Martinsried, Germany

12:00 - 13:30 Lunch Break

Chair: Dr. Christian Albers, Bruker Daltonics GmbH & Co. KG, Bremen, Germany

13:30 - 14:00 Complementary MS method for assessing structural changes in monoclonal antibodies
Manasi Gaikwad – Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

14:00 - 14:20 PreON: Highly efficient automated LC/MS sample preparation up and running in your facilities within one day
Russel Golson, PreOmics, München, Germany

14:20 - 14:50 High-Throughput Host Cell Protein Analysis in Industrial Biotechnology
Dr. Christian Jörgensen, Novozymes A/S, Bagsvaerd, Denmark

14:50 - 15:20 In-depth characterization of therapeutic oligonucleotides by timsTOF pro and Bruker OligoQuest
Dr. Youzhong Lui, Janssen Pharmaceuticals, Beerse, Belgium

15:20 - 15:50 Break

Chair: Mike Greig, Bruker Scientific LLC, Billerica, US

16:50 - 16:20 Termini-dissected characterization of protein-based biologic by TIMS-enabled Next-Generation MALDI Top-Down sequencing
Dr. Arndt Asperger, Bruker Daltonics GmbH & Co. KG, Bremen, Germany

16:20 - 16:50 Characterization of antigenic glycoproteins
Dr. Michel Plisnier, GSK, Rixensart, Belgium

16:50 - 17:20 Assessing the Immunogenicity of Biopharmaceuticals using immunopeptidomics
Dr. Duong Nguyen, Octapharma Biopharmaceuticals GmbH, Berlin, Germany

17:20 - 17:50 High resolution intact and sub-unit protein mass spectrometry for the characterization of biopharmaceuticals
Dr. Christopher Lößner, Boehringer Ingelheim, Biberach, Germany

17:50 - 19:00 Networking

Chair: Dr. Naomi Vos, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

9:00 - 09:50 Keynote Speaker: Dr. Peter Marshall, GSK, Stevenage, United Kingdom

09:50 - 10:30 Coffee Break

Chair: Dr. Mike Easterling, Bruker Scientific LLC, Billerica, US

10:30 - 11:00 The “I” is for Imaging… MSI application examples in pharmaceutical Research and Development
Dr. Michael Becker – Boehringer Ingelheim, Biberach, Germany

11:00 - 11:30 Spatial omics to investigate intra-tumor heterogeneity of sulfatides in cholangiocarcinoma
Kasper Krestensen, M4I-University of Maastricht, Netherlands

11:30 - 12:00 Biomarker discovery at Sanofi: Linking untargeted biomarker discovery with UHR-MALDI- Imaging
Dr. Bogdan Muntenau, Sanofi, Frankfurt, Germany

12:00 - 13:30 Lunch Break (and Tours of the Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), MSI Facility)

Chair: Dr. Alexandra Iakab, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

13:30 - 14:00 FROM LABORATORY TO HOSPITAL: Empowering clinical diagnostics with translational Mass Spectrometry Imaging
Dr. Eva Cuypers, M4I-University of Maastricht, Maastricht, Netherlands

14:00 - 14:30 TIMI - Tissue Imaging using MALDI and Immunohistochemistry
Dr. Mark Lim, Ambergen, Watertown, US

14:30 - 15:00 Coffee Break

Chair: Dr. Michele Genangeli, Bruker Nederland B.V., Leiderdorp, Netherlands

15:00 - 15:30 Assessing small molecule distributions in 3D cell culture models by 3D-MALDI Imaging
Dr. Alexandra Iakab, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

15:30 - 16:00 Insights into Alzheimer Pathology Using Multimodal Chemical Imaging
Dr. Jörg Hanrieder, Department of Psychiatry and Neurochemistry, University of Gothenburg, Sweden

16:00 - 16:15 Closing remarks
Dr. Eric van Beelen, Bruker Nederland B.V., Leiderdorp, Netherlands

For further information, please contact:

Anne Kropp
Bruker Daltonics GmbH & Co. KG
Fahrenheitstrasse 4
28359 Bremen
anne.kropp@bruker.com